CNBX PHARMACEUTICALS INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CNBX PHARMACEUTICALS INC. (CNBX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $70.50 thousand for the 12-month period ending 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-12-01
- CNBX PHARMACEUTICALS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $70.50K, a 45.29% decline from fiscal 2024.
- CNBX PHARMACEUTICALS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $128.85K, a 78.66% decline from fiscal 2023.
- CNBX PHARMACEUTICALS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $603.89K, a 42.76% decline from fiscal 2022.
- CNBX PHARMACEUTICALS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.06M, a 48.57% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-08-31 | $70.50K 10-K · filed 2025-12-01 | |
| 2024-08-31 | $128.85K 10-K · filed 2025-12-01 | |
| 2023-08-31 | $603.89K 10-K · filed 2024-11-29 | |
| 2022-08-31 | $1.06M 10-K · filed 2023-11-30 | |
| 2021-08-31 | $710.18K 10-K · filed 2022-11-30 | |
| 2020-08-31 | -$1.62M 10-K · filed 2021-11-29 | $1.67M 10-K · filed 2020-11-04 |
| 2019-08-31 | -$234.55K 10-K · filed 2020-11-04 | |
| 2018-08-31 | $1.11M 10-K · filed 2018-11-29 | |
| 2017-08-31 | $598.07K 10-K · filed 2018-11-29 | |
| 2016-08-31 | $91.40K 10-K · filed 2017-12-08 | $81.91K 10-K · filed 2016-12-13 |
| 2015-08-31 | $183.94K 10-K · filed 2016-12-13 | $183.84K 10-K · filed 2016-01-07 |
| 2014-08-31 | $87.14K 10-K · filed 2016-01-07 | |
| 2013-08-31 | $19.70K 10-K/A · filed 2015-10-23 | |
| 2012-08-31 | $578.00 10-K · filed 2012-11-30 |